US OptionsDetailed Quotes
TEM250103C65000
- 0.05
- 0.000.00%
15min DelayTrading Jan 3 16:00 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume31 Open Interest65.00Strike Price0.00Turnover0.00%IV61.33%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma806.40Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Tempus AI Stock Discussion
FDA offers new draft guidance to developers of AI-enabled medical devices
The FDA's proposed framework to enhance the credibility of AI models in drug and biological product submissions is poised to impact both the pharmaceutical and technology sectors. This initiative aims to provide clear guidelines for AI applications in drug development, potentially accelerating innovation and regulatory approvals.
No comment yet